Background: This multicenter prospective cohort study aimed to identify both ability of echocardiographic parameters to detect cardiac resynchronization therapy (CRT) volume responders and relation of these parameters with clinical outcomes.
ardiac resynchronization therapy (CRT) by means of bi-ventricular pacing has been established by large clinical trials as a non-pharmacologic therapy for patients with drug-refractory heart failure and dyssynchrony. 1-3 These studies showed that CRT significantly improves heart failure symptoms, quality of life, exercise tolerance, and left ventricular (LV) systolic performance. The indication of CRT has been extended even in pediatrics. 4 However, approximately 30% of patients do not respond to bi-ventricular pacing, and inadequate selection criteria for identifying potential responders based on QRS duration result in a high rate of non-responders. 5, 6 Alternatively, numerous Doppler echocardiographic parameters have been proposed to improve prediction of CRT responders, and echocardiography has had a central role in this prediction. 7-11 However, some limitations of echocardiography to predict CRT responders are causes of concern. First, echocardiographic parameters have been reported from single-center studies. Recently, the results of the Echocardiography to Predict CRT Responders Predictors of Response to CRT (PROSPECT) trial, a multicenter prospective cohort study to evaluate selected, predefined baseline echocardiographic parameters for their ability to predict clinical and echocardiographic response to CRT, were published. 12 The PROSPECT study showed that no single echocardiographic measure of dyssynchrony had the ability to predict CRT responders. However, the PROSPECT trial has been the only such multicenter trial to date. Therefore, the predictive ability of echocardiographic parameters requires verification by further studies. In addition, an appropriate method to evaluate the effects of CRT has not been standardized. Because LV reverse remodeling using LV endsystolic volume reduction has been used as a surrogate of CRT responders, identification of predictors of volume responders has been a focal issue. However, the role of volume responders as a surrogate of clinical outcomes has not been confirmed in multiple cohort studies. Finally, although clinical outcomes after CRT have been used as endpoints in large trials and associated factors unrelated to echocardiographic parameters have been identified, the relation between predefined baseline echocardiographic parameters and clinical outcomes has not been determined. 1-3, 5 Considering these unresolved issues, a multicenter prospective cohort study was conducted in Japan to assess the following: (1) the ability of predefined baseline echocardiographic dyssynchrony parameters to predict volume responders after CRT, (2) implications of volume responders as a surrogate of clinical outcomes, and (3) the ability of baseline echocardiographic dyssynchrony parameters to predict clinical outcomes after CRT.
Editorial p 1053 Methods
The Japan Cardiac Resynchronization Therapy Registry Trial (J-CRT) was a multicenter prospective cohort study of patients undergoing CRT in Japan. The study was approved by the local ethics committee of each participating institution.
All patients provided their written informed consent. A 2-day workshop to acquaint participating echocardiologists and electrophysiologists with the study protocol and echocardiographic recording was performed by the J-CRT Committee in August 2005, in Tokyo.
Study Population
Patient inclusion criteria included presence of congestive heart failure refractory to optimal medical therapy and QRS duration ≥120 ms, New York Heart Association (NYHA) class III or IV, and LV ejection fraction (LVEF) ≤35%. Patients were excluded if they were expected to die within 1 year because of non-cardiac disease, if they were scheduled for catheter intervention or cardiac surgery including cardiotomy or coronary bypass, or if they were expected to be lost to follow-up during the first year after CRT. Patients were scheduled to undergo Doppler echocardiographic studies with NYHA functional class assessment and measurements before, and at 1 week, 6 months, and 12 months after CRT. Patients were followed up for at least 6 months.
CRT Responders and Clinical Endpoints
A volume responder to CRT was defined as a patient with ≥15% reduction of LV end-systolic volume at 6 months after CRT. 12 Clinical outcomes were assessed with the following endpoint: a composite of death from any cause or an unplanned hospitalization for a major cardiovascular event.
Doppler Echocardiography and Dyssynchrony Parameters
The echocardiographic measurements were performed by cardiologists or well trained sonographers in each individual center in a prospective way, not knowing the patients' outcome. In Doppler echocardiographic examinations, LV volumes, LV dimensions, LV wall thickness, left atrial (LA) dimension, Doppler-derived parameters of LV diastolic function, mitral regurgitation severity as the ratio of color Doppler mitral regurgitant jet area to LA area, and pressure gradients derived from tricuspid regurgitant flow were assessed by standard methods. In this study, 7 dyssynchrony parameters, 
Statistical Analysis
Data are presented as mean ± standard deviation or percentages. Comparisons between groups were performed with unpaired Student's t-test used for continuous variables and χ2 tests used for categorical variables. We assessed the performance of each dyssynchrony parameter to predict volume responders and ≥1 class improvement of NYHA class at 6 months after CRT using the area under the curve of the receiver operating characteristic curve (AUC). Independent determinants of the volume responders were assessed by logistic regression analysis. The risk of clinical endpoints was determined with Cox proportional hazard models. The univariate factors with a value of P<0.05 and age and male sex were entered into the multivariable model to assess the impact of the parameters on the endpoint. Kaplan -Meier analysis was done to determine the influence of volume responders on the endpoint. A P-value <0.05 was considered to indicate statistical significance. Analyses were performed with SPSS version 17.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results

Baseline Characteristics
The J-CRT trial enrolled 225 patients who were initially implanted with CRT devices in 18 Japanese centers. Enrollment began in April 2006 and ended in July 2008, and 6-month follow-up was completed in March 2009. In the entire cohort, Atrial fibrillation 27 (13) 15 (12) 11 (14) Pacemaker 39 (18) 26 (20) 15 ( (11) 8 (6) 14 (18) Non-specific 61 (28) 30 (23) 26 (34) Primary ventricular tachyarrhythmia, n (%) 0.67
Sustained VT 30 (14) 19 (15) 8 (10) Non-sustained VT 73 (34) 44 (34) 27 (35) Ventricular fibrillation 11 (5) 6 (5) 4 (5) Other arrhythmia, n (%) 0.46
Paroxysmal atrial fibrillation 30 (14) 15 (12) 15 (20) Chronic atrial fibrillation 25 (12) 15 (12) 8 (11) Atrial flutter 8 (4) 3 (2) 4 (5) BNP, pg/ml 693±766 670±757 612±505 0.56
Medication, n (%)
Intravenous inotropes 20 ( ) were excluded because of CRT discontinuation immediately after implantation (n=3), withdrawal of consent (n=1), and incomplete data (n=4). Ultimately, 217 patients formed the final study group of the present report ( Table 2) . Almost all patients were NYHA class III, and the majority of the patients had non-ischemic heart disease, a history of non-sustained ventricular tachycardia, and left bundle branch block (LBBB).
Clinical Outcomes
The mean duration of follow-up was 288±177 days (range, 13 to 608 days). By the end of the study, 51 patients had reached the endpoint of a composite of death from any cause or unplanned hospitalization for a major cardiovascular event.
Deaths occurred in 19 patients (9%): 11 patients died of heart failure, 6 died of non-cardiac death, and only 2 patients died from sudden cardiac death. Unplanned hospitalizations occurred in 23 patients for heart failure and in 9 patients for other cardiovascular events.
Volume Responder Study
LV volume measurements at 6 months were completed in 207 of 217 patients. Six-month data in the remaining 10 patients could not be assessed due to death in 9 patients (from heart failure in 4, sudden cardiac death in 1, and non-cardiac death in 4 and to loss to follow-up in 1 patient with cerebral infarction. Of the 207 patients, 130 (63%) were identified as volume responders to CRT. Comparisons of baseline patient characteristics between the responder group and non-responder group are summarized in Table 2 . Patients in the responder group were older and showed greater prevalence of LBBB compared to those in the non-responder group. The prevalence of patients being administered intravenous or oral inotropes was higher in the non-responder group, whereas the prevalence of patients being administered a β-blocker was less in the responder group. Tables 1,2 
. Echocardiography to Predict CRT Responders
Baseline echocardiographic parameters are compared in Table 3 . Only transtricuspid pressure gradient was significantly higher in the non-responder group than in the responder group. Baseline dyssynchrony parameters are summarized in Table 4 . The baseline evaluable rate of each parameter did not differ between the groups. Of the 7 dyssynchrony parameters, only septal-to-posterior wall motion delay (SPWMD), interventricular mechanical delay (IMD), and delay between time to peak systolic velocity in ejection phase at basal septal and lateral segments (Ts (lateral-septal)) were significantly higher in the responder group than in the non-responder group. The AUC to predict volume responders for each dyssynchrony parameter are listed in Table 5 . Of all dyssynchrony parameters, SPWMD showed the highest AUC value (0.65), followed by that of IMD at 0.64. In addition, the AUC to predict ≥1 class improvement of NYHA class at 6 months after CRT are listed in Table 6 . SPWMD showed the highest AUC value (0.68).
Baseline predictors of a volume responder are shown in Table 7 . In a multivariate logistic regression analysis, presence of LBBB, administration of intravenous inotropes, and non-administration of β-blockers were identified as the independent predictors of a volume responder. For the presence of LV dyssynchrony, univariate logistic regression analysis showed SPWMD >130 ms to be associated with volume responders, but it was not an independent predictor in multivariate model 1. In contrast, a combined dyssynchrony criterion that required at least one of SPWMD >130 ms or Ts (lateralseptal) >65 ms was independently associated with volume responders in multivariate model 2.
Outcomes and Volume Responders
Kaplan -Meier estimates of the time to the endpoint is shown in Figure. There were significantly fewer events in the volume responder group than in the non-responder group (log rank, P<0.001). Of the 15 events in the responder group, heart failure was the cause of death in 2 patients and of unplanned hospitalizations in 6 patients, and other cardiovascular events were the cause of unplanned hospitalizations in 7 patients. Of the 26 events in the non-responder group, heart failure was the cause of death in 5 patients and of unplanned hospitalizations in 17 patients. Sudden cardiac death occurred in 1 patient, and non-cardiac death occurred in 2 patients. Other cardiovascular events were the cause of unplanned hospitalization in 1 patient. 
Baseline Parameters and Clinical Outcomes
Univariate Cox proportional hazard analyses adjusted for age and sex revealed the relations of 6 predefined parameters with a composite of death from any cause or an unplanned hospitalization for a major cardiovascular event ( Table 8) . Because 3 dyssynchrony parameters were associated with the endpoint, 3 multivariate analysis models combined with each dyssynchrony parameter were assessed, and SPWMD >130 ms or a combined dyssynchrony criterion that required at least one of SPWMD >130 ms or Ts (lateral-septal) >65 ms was associated with the endpoint independently of the presence of LBBB. In contrast, presence of a wide QRS of >150 ms was not independently associated with the endpoint.
Discussion
The present study showed the following major findings regarding the relation between Doppler echocardiographic parameters and CRT effect. Although the volume responders showed better outcomes compared to the volume non-responders, no dyssynchrony parameter could independently predict CRT volume responders. In addition, single dyssynchrony parameters could not predict NYHA class improvements after CRT. In contrast, a combined dyssynchrony criterion of parameters to detect dyssynchrony between the septum and LV free wall was associated with volume responders and the clinical outcome independently of QRS duration and presence of LBBB.
Intraventricular Dyssynchrony and Cardiac Remodeling After CRT
A dyssynchrony criterion combining SPWMD and Ts (lateralseptal) was independently associated with volume responders but each criterion alone did not appear to independently have significant power to detect volume responders, similar to the findings of the PROSPECT study. 12 As a rationale for the use of CRT with bi-ventricular pacing, LV mechanical dyssynchrony between the septum and free wall is a primary target for resynchronization by LV free-wall pacing. 13, 14 Then, the present results are reasonable because the detection of typical mechanical dyssynchrony between the septum and free wall, which can be detected by SPWMD and Ts (lateral-septal), is a key concept for the use of Doppler echocardiography to predict CRT responders. Although multiple factors including NYHA class at baseline and etiology of heart failure are associated with LV reverse remodeling after CRT, as is also shown in a sub-analysis of the PROSPECT study, at the least, the presence of mechanical dyssynchrony between the septum and free wall at baseline should be a key indicator of LV reverse remodeling after CRT. 15 In contrast, the presence of LBBB was the strongest predictor of CRT benefit. The finding suggests that the presence of LBBB can predict the presence of mechanical dyssynchrony between the septum and free wall more accurately than present echocardiographic parameters.
Issues With Cardiac Dyssynchrony Parameters
The modest power of SPWMD and Ts (lateral-septal) to predict volume responders raises some issues in the quantification of important dyssynchrony patterns by the Doppler echocardiographic parameters. In the present study, about one half (49%) of the patients who had mechanical dyssynchrony as identified by either the SPWMD or Ts (lateral-septal) definition had mechanical dyssynchrony identified by both the SPWMD and Ts (lateral-septal) parameters. This disagreement convincingly illustrates the issues of parameter measurements, despite the differences in motion analysis modalities and direction in longitudinal or radial motions. On the basis of the original definition of SPWMD, the surrogate points depend on the magnitude of displacement and the shortest interval between the maximum displacement peaks between septum and posterior wall, independent of the timing of the peaks. 7 In addition to M-mode images without peaks associated with reduced wall motion, the determinant of a surrogate peak in the multiple samples of the septum on an M-mode image is also of great concern as instances in which measurements are impossible. 16,17 For Doppler-derived Ts (lateralseptal) measurements, the limited measurement phase during the LV ejection period might be an issue. Recently, septal flash motion has been receiving attention as a useful marker of CRT responders and is commonly observed in early systole including the pre-ejection period. 14,18,19 Thus, phase-restricted measurements cannot detect early septal contractions. 20 In addition, an atypical dyssynchrony pattern, in which a lateral peak occurs earlier than a septal peak, might be observed even in patients with typical LBBB. 21 In such cases, the time difference does not associate with the typical mechanical dyssynchrony sequence.
Mechanical Dyssynchrony and CRT Effect
The present study shows that mortality and morbidity rates of volume responders were better than those of non-responders. Therefore, the volume responder is a reliable surrogate of CRT effects, and patients who can be predicted to undergo reverse remodeling should be selected as the first candidates for CRT. 15,21, 22 In contrast, 10 patients in the present study were excluded due to the occurrence of fatal events within 6 months after CRT, which suggests the limitation of volume responder criteria as a method of evaluating CRT effects. More importantly, the J-CRT trial is the first multicenter study to reveal the relation between predefined baseline echocardiographic dyssynchrony parameters and clinical outcome because earlier large trials did not use echocardiographic parameters to assess clinical outcomes in patients with CRT, except in a part of the Cardiac Resynchronization-Heart Failure (CARE-HF) Study results. 3 Dyssynchrony between the septum and LV free wall was associated with clinical outcome as well as volume responders. In the PROSPECT study, 12 a heart failure clinical composite score (CCS) that combined all-cause mortality, heart failure hospitalization, NYHA class, and patient global assessment into an outcome measure was used to assess the relation between dyssynchrony parameters and clinical outcomes. Although the CCS was evaluated as an outcome at 6 months after CRT, there was a discrepancy in relation to dyssynchrony parameters between the CCS and volume responders. Possible explanations for this finding are that the CCS includes relatively subjective data such as NYHA class and patient global assessment, and the duration of follow-up observation might be too short to assess clinical outcomes in patients with CRT. As a novel proposal, more accurate means of echocardiographic detection of LV dyssynchrony should be developed that focus on the electrical and mechanical dyssynchrony sequence that can be treated with CRT. If this is done, echocardiography might occupy a more critical role in the selection of CRT candidates and can be a more accurate predictor of the beneficial effects of CRT. In addition, the comparison between echocardiography and other imaging modalities including electrocardiogram-gated single-photon emission computed tomography myocardial perfusion imaging and magnetic resonance imaging might be Echocardiography to Predict CRT Responders useful in identifying the need for mechanical dyssynchrony imaging. 23 
Study Limitations
The reproducibility of echocardiographic parameter measurements was not assessed in the present study. Although an echocardiographic recording workshop was provided to participating echocardiologists and electrophysiologists by the J-CRT Committee, data variability among the institutions participating in the J-CRT study might have affected the results as poor reproducibility was also shown in the PROSPECT study. 12 
Conclusions
Current echocardiographic parameters do not have significant power to detect clinical improvements and LV reverse remodeling after CRT, which has been identified as a reliable surrogate of clinical outcomes in patients with CRT. However, intraventricular dyssynchrony measured between the septum and LV free wall might be associated not only with CRT volume responders but also with the clinical outcome. These relations suggest that intraventricular mechanical dyssynchrony between the septum and LV free wall might be a key to the prediction of CRT benefit. Therefore, further studies are needed to identify the parameter that most accurately detects the mechanical dyssynchrony sequence.
